AXA stock advances on resilient earnings and capital strength

AXA (FR0000120620) anchors today’s read with a €5.9 billion 2024 underlying earnings base, €34.3 billion in underlying revenues, and a Solvency II ratio of 216% at year-end 2024. Those figures matter because they frame the insurer’s capital cushion and profit engine more clearly than a headline price move alone.

€5.9 billion earnings base

AXA reported €5.9 billion in underlying earnings for 2024, up 8% from 2023, while underlying revenues reached €34.3 billion in the same period. The group also reported a Solvency II ratio of 216% at 31 December 2024, which gives investors a dated capital reference rather than a vague balance-sheet label.

The comparison is the key point: 2024 underlying earnings of €5.9 billion versus 2023 at a lower level, and a 216% solvency ratio against a regulatory capital framework that the market tracks closely. AXA also said it returned €2.1 billion to shareholders through share buybacks and dividends in 2024, adding another measurable cash-distribution element.

Capital and payouts

The capital story is not only about the ratio. AXA’s 2024 shareholder return of €2.1 billion and the 2024 earnings increase together suggest a group that kept both profit generation and capital distribution visible in the same reporting year.

For investors following European insurers, that mix is central: earnings grew 8% year on year, revenues stood at €34.3 billion, and capital coverage remained at 216% at the close of 2024. Those are the three numbers that best frame the stock without drifting into broad sector commentary.

Property and casualty scale

AXA’s property and casualty business remains one of the group’s most relevant operating drivers, alongside life, health, and asset management. The 2024 report showed that the group’s earnings base and revenue scale were broad enough to support all three business lines without relying on a single segment.

That matters for the stock because it reduces the story to measurable operating breadth: €34.3 billion in underlying revenues, €5.9 billion in underlying earnings, and a 216% Solvency II ratio at year-end 2024. Each number comes from the same reporting cycle, which keeps the comparison internally consistent.

2024 revenue scale

AXA’s 2024 underlying revenues of €34.3 billion provide the clearest product-level backdrop for the group’s insurance book. The number is large enough to show the breadth of the franchise, but the more useful metric is the 8% year-on-year increase in underlying earnings, because it links top-line scale to bottom-line performance.

In practical terms, the stock story is still about whether capital, payouts, and earnings growth stay aligned. On that score, the 2024 figures provide a clean baseline: €5.9 billion underlying earnings, €34.3 billion underlying revenues, and €2.1 billion returned to shareholders.

Capital, dated

AXA closed 2024 with a 216% Solvency II ratio, a percentage that market participants use to gauge capital headroom in a regulated insurer. The date matters as much as the percentage, because the ratio is a year-end snapshot rather than a rolling estimate.

The stock closing reference is therefore the year-end 2024 balance-sheet picture rather than an unverified live quote. For AXA, that picture is built around €5.9 billion underlying earnings, €34.3 billion underlying revenues, 216% Solvency II, and €2.1 billion in shareholder returns for 2024.

AXA insurance and health lines

AXA’s insurance and health businesses sit at the center of the group’s reporting profile, with the 2024 numbers showing how diversified underwriting and investment income feed the consolidated result. The company’s 2024 annual report and investor materials remain the best source for that segment mix and its capital implications.

AXA stock as of 2024

AXA stock is best read through the latest reported numbers rather than a short-term narrative. The 2024 base shows €5.9 billion in underlying earnings, €34.3 billion in underlying revenues, and a 216% Solvency II ratio, all of which were reported for the full year 2024 and remain the key dated reference points in this article.